NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
0.6365
Dollar change
-0.0905
Percentage change
-12.45
%
Index- P/E- EPS (ttm)-0.07 Insider Own35.94% Shs Outstand78.20M Perf Week-20.34%
Market Cap49.95M Forward P/E- EPS next Y-0.03 Insider Trans-0.80% Shs Float50.27M Perf Month-33.35%
Enterprise Value48.02M PEG- EPS next Q-0.01 Inst Own5.33% Short Float0.18% Perf Quarter-35.71%
Income-5.27M P/S5.80 EPS this Y16.67% Inst Trans-10.40% Short Ratio1.29 Perf Half Y-25.12%
Sales8.61M P/B11.15 EPS next Y40.00% ROA-51.55% Short Interest0.09M Perf YTD-33.70%
Book/sh0.06 P/C22.20 EPS next 5Y- ROE-88.36% 52W High1.39 -54.29% Perf Year-2.38%
Cash/sh0.03 P/FCF- EPS past 3/5Y15.83% 18.51% ROIC-113.42% 52W Low0.57 11.67% Perf 3Y-33.00%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-5.74% 0.60% Gross Margin73.85% Volatility18.19% 7.50% Perf 5Y-73.48%
Dividend TTM- EV/Sales5.58 EPS Y/Y TTM30.04% Oper. Margin-84.63% ATR (14)0.07 Perf 10Y-80.10%
Dividend Ex-Date- Quick Ratio1.00 Sales Y/Y TTM-9.13% Profit Margin-61.16% RSI (14)20.98 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.94 EPS Q/Q-34.81% SMA20-25.33% Beta0.84 Target Price1.25
Payout- Debt/Eq0.07 Sales Q/Q-0.73% SMA50-30.60% Rel Volume3.65 Prev Close0.73
Employees17 LT Debt/Eq0.04 EarningsMay 15 AMC SMA200-32.60% Avg Volume68.55K Price0.64
IPONov 03, 1995 Option/ShortYes / Yes EPS/Sales Surpr.-100.00% -10.70% Trades Volume250,064 Change-12.45%
Date Action Analyst Rating Change Price Target Change
Sep-16-20Initiated Northland Capital Market Perform
Nov-16-18Reiterated Maxim Group Buy $3 → $1.50
Dec-23-16Reiterated Maxim Group Buy $5 → $4
Dec-11-15Initiated Maxim Group Buy $5
May-19-25 10:00AM
May-15-25 04:15PM
Apr-15-25 04:10PM
Apr-02-25 08:36AM
Apr-01-25 08:30AM
10:00AM Loading…
Feb-04-25 10:00AM
Jan-23-25 11:00AM
Dec-04-24 12:00PM
Nov-26-24 08:30AM
Nov-16-24 02:01AM
Nov-14-24 04:30PM
04:00PM
07:19AM
Nov-12-24 08:30AM
Nov-01-24 09:15AM
11:00AM Loading…
Oct-03-24 11:00AM
Aug-15-24 07:00AM
Aug-12-24 11:00AM
Aug-07-24 10:00AM
Jul-30-24 08:30AM
Jul-23-24 08:30AM
Jul-10-24 08:30AM
Jun-18-24 11:00AM
May-16-24 07:00AM
May-13-24 08:30AM
Apr-03-24 08:30AM
Apr-01-24 07:00AM
Mar-28-24 11:45AM
Mar-14-24 08:30AM
Feb-28-24 08:30AM
08:30AM Loading…
Feb-20-24 08:30AM
Jan-16-24 08:30AM
Dec-13-23 05:00PM
Dec-10-23 08:33PM
Dec-08-23 04:03PM
08:30AM
Nov-28-23 08:30AM
Nov-15-23 07:00AM
Nov-10-23 08:30AM
Nov-09-23 08:30AM
Sep-12-23 11:00AM
Aug-15-23 07:00AM
Aug-09-23 04:05PM
08:30AM
Jun-15-23 11:00AM
May-16-23 08:30AM
May-11-23 07:00AM
May-10-23 08:30AM
May-09-23 08:30AM
May-05-23 11:00AM
Mar-31-23 07:00AM
Mar-29-23 08:30AM
Mar-14-23 09:15AM
Mar-10-23 09:00AM
Mar-02-23 08:30AM
Feb-27-23 11:00AM
Jan-12-23 08:30AM
Jan-10-23 08:30AM
Jan-05-23 08:15AM
Nov-15-22 07:00AM
Nov-10-22 08:30AM
Oct-06-22 09:00AM
Aug-18-22 08:30AM
Aug-16-22 07:00AM
Aug-12-22 08:30AM
Aug-04-22 08:30AM
Aug-02-22 08:30AM
Jul-19-22 08:30AM
Jul-12-22 08:30AM
Jul-07-22 08:30AM
Jul-06-22 11:00AM
May-27-22 08:00AM
May-23-22 08:00AM
May-17-22 07:00AM
May-13-22 11:00AM
Apr-29-22 01:16PM
Apr-14-22 11:00AM
07:30AM
Apr-11-22 08:30AM
Apr-01-22 07:00AM
Mar-29-22 02:00PM
09:00AM
Feb-07-22 09:00AM
Jan-28-22 10:07AM
Jan-18-22 08:30AM
Jan-10-22 08:30AM
Jan-07-22 09:00AM
Dec-28-21 08:30AM
Dec-23-21 08:30AM
Dec-22-21 11:00AM
Dec-15-21 04:05PM
Dec-01-21 08:30AM
Nov-15-21 07:30AM
Nov-11-21 08:30AM
Nov-09-21 03:00PM
Oct-18-21 08:30AM
Oct-14-21 08:30AM
Oct-05-21 09:00AM
Oct-04-21 04:30PM
08:30AM
Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. It operates through the following segments: Dental, Medical, and Corporate. The Corporate segment refers to executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities, and public company compliance costs. Its solutions include CompuFlo Epidural, CathCheck Verification System, and Single Tooth Anesthesia System. The company was founded on August 17, 1989 and is headquartered in Roseland, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BP4 S.r.l.10% OwnerJun 16 '25Sale0.9010,0569,0019,447,183Jun 20 09:51 AM
BP4 S.r.l.10% OwnerJun 18 '25Sale0.881,6931,4909,445,490Jun 20 09:51 AM
BP4 S.r.l.10% OwnerJun 11 '25Sale0.9023,79721,4659,457,239Jun 16 09:10 AM
BP4 S.r.l.10% OwnerJun 10 '25Sale0.9130,10027,3739,481,036Jun 11 04:02 PM
BP4 S.r.l.10% OwnerJun 09 '25Sale0.9120,26618,3419,511,136Jun 11 04:02 PM
BP4 S.r.l.10% OwnerJun 06 '25Sale0.9060,20054,2649,531,402Jun 10 11:22 AM
BP4 S.r.l.10% OwnerJun 05 '25Sale0.9126,85524,4499,591,602Jun 10 11:22 AM
BP4 S.r.l.10% OwnerJun 03 '25Sale0.948,0007,4959,624,457Jun 06 02:14 PM
BP4 S.r.l.10% OwnerJun 04 '25Sale0.916,0005,4689,618,457Jun 06 02:14 PM
BP4 S.r.l.10% OwnerMay 30 '25Sale0.9312,11811,2789,642,457Jun 03 04:00 PM
BP4 S.r.l.10% OwnerJun 02 '25Sale0.9510,0009,4669,632,457Jun 03 04:00 PM
BP4 S.r.l.10% OwnerMay 28 '25Sale0.9614,25613,6869,658,192May 30 05:08 PM
BP4 S.r.l.10% OwnerMay 29 '25Sale0.963,3613,2279,654,831May 30 05:08 PM
BP4 S.r.l. (MLSS)10% OwnerMay 23 '25Proposed Sale1.05550,000575,500May 22 04:14 PM
McGeehan MichaelDirectorDec 19 '24Sale0.7820,00015,532575,273Dec 20 04:00 PM
McGeehan MichaelDirectorDec 19 '24Proposed Sale0.7946,87937,034Dec 19 12:18 PM
OSSER LEONARDDirectorOct 22 '24Sale0.93107,984100,4254,606,882Oct 23 04:55 PM
McGeehan MichaelDirectorSep 24 '24Sale1.00209209595,273Sep 27 09:12 AM
McGeehan MichaelDirectorSep 20 '24Sale1.001,8001,800593,682Sep 24 03:41 PM
McGeehan MichaelDirectorSep 19 '24Sale1.001,0001,000595,482Sep 24 03:41 PM
McGeehan MichaelDirectorSep 11 '24Proposed Sale0.9650,10748,103Sep 11 01:07 PM
OSSER LEONARDDirectorAug 21 '24Sale0.95141,913134,8174,602,506Aug 21 05:03 PM